for pharmaceutical manufacturing
in West Africa
Vision
Our vision is to become Africa’s premier healthcare • We are dedicated to developing,
company, providing innovative and affordable healthcare manufacturing and marketing high quality
solutions to the continent. We are establishing ourselves branded and generic pharmaceutical products
& as a world class, self-sufficient pharmaceutical
manufacturer that fully integrates active pharmaceutical
that cure disease and enhance the quality of
life in Africa.
Mission ingredient manufacturing into finished dosage form
production, enabling a tight control of quality and ready
availability of our products.
• We nurture a safe, healthy and creative
atmosphere in which our employees respect
each other and the quality of the products we
We will become the most valued employer, healthcare manufacture.
supplier, business partner and corporate citizen in the
region. Our hallmark is quality: in our products, our • We operate in a sustainable manner,
people and our processes. scientifically, economically, socially and
environmentally.
Lasting solutions to
Africa’s healthcare
problems through
sustainable
technological growth
We are a fully vertically integrated pharmaceutical Our strategy is to manufacture most products,
manufacturing company with the technology to starting from synthetic intermediates through the
manufacture both active pharmaceutical ingredients (API) APIs to the finished dosage forms, in a vertically
History and finished dosage forms. We are the first API
manufacturer in West Africa.
integrated manner.
This, we believe:
The venture commenced in 2001 with the construction of
a modern fine chemicals and pharmaceutical • Enables control of quality from start to finish
manufacturing facility at Nsawam, in the Eastern Region • Favorably positions us for voluntary licenses
of Ghana. and technology transfers
• Enables the manufacture of many products
Commercial production started in July 2007 and the total in a self-sufficient manner.
number of employees as of January 2008 is 55.
LaGray Chemical Company
Nsawam, Ghana
+233.832.22332
info@[Link]
[Link]
From concept to implementation, the objective was Some salient cGMP features of our facility are:
Facility
to build the company’s facility in accordance with the
latest international guidelines for the design of • Controlled access
premises for pharmaceutical manufacturing. • Class 100,000 minimum air quality, class
10,000 (ISO 7.0) in critical areas
We are thus adhering to the principles of current • Separate personnel and material entrances in
Good Manufacturing Practices (cGMP) for manufacturing areas
pharmaceutical products. Our facility is designed to • USP grade water in an RO water loop system
control the flow of personnel and material so as to • Smooth seamless epoxy floor finishing, coving
avoid confusion. The air quality is controlled in order of all joints and flush view panels to facilitate
to prevent cross-contamination. cleaning.
Products
The company’s manufacturing capacity is 10 metric Our product portfolio comprise:
tons of API, 8 million laminated aluminum tubes of • Azithromycin bulk drug
dermatological products and 300 million filled hard • Dermatologicals for the treatment of a variety
gelatin capsules per year for a single shift operation. of conditions including dermatomycoses and
pyoderma
The strategy for finished products is to focus on local • Antiinfectives against bacterial and fungal
and sub-regional unmet drug needs. Our objective infections such as respiratory tract, urinary
for the near future is to attain 1% share of the $1 tract and opportunistic infections in HIV AIDS
billion West African pharmaceutical market. Hence • Antihypertensives
Superior quality registration of our products are currently filed in 16 We are currently developing our portfolio in
pharmaceuticals from African countries increase API manufacturing antiretrovirals and antimalarials. In that regard, we
start to finish, focused capacity and our long term goal is to build a are seeking:
healthcare company with capabilities in •
on Africa pharmaceuticals, vaccines and diagnostics.
Strategic partnering for voluntary licenses and
technology transfers
Partnering for research and development of
. antimalarial drugs
2
Quality
We employ a modern quality systems based Equipment includes HPLCs, FTIR and atomic absorption
approach to cGMP compliance with the goal of spectrometer.
producing safe and effective medications • Our microbiology laboratory is a BSL2 laboratory
consistently and in a sustainable manner. and is equipped to handle level 2 organisms safely
Our quality control function consists of fully
• Our Laboratory Information Management System
(LIMS) is 21 CFR Part 11 compliant
equipped analytical chemistry, instrumentation
and microbiology laboratories.
People
The Founders and Directors of the company We have a well qualified and highly trained workforce
have decades of experience working for major that includes personnel in disciplines such as
pharmaceutical companies (Abbott, Upjohn, Pharmaceutical Sciences, Chemical Engineering,
Pharmacia and Pfizer) in the USA Chemistry and Microbiology
Designed, built and
operating in
compliance with
international
standards of current
Good Manufacturing
Practices
Corporate We are a socially responsible corporate
citizen. Our campus is an aesthetically
Citizenship pleasing green oasis that provides gainful
employment to the surrounding community.
We have equipped our facility with
environmental protective systems such as:
• An emission scrubber to ensure that no
significant amounts of water soluble
gases are released freely into the
atmosphere
• A comprehensive aqueous effluent
treatment system that recycles process
water for irrigation
3
Markets We have registered our products in more than
15 countries in West and Central Africa. The
We are thus setting up strategic alliances with marketing
companies and distributors throughout the region.
objective is to establish brand recognition and
a good distribution system for the long term.
Launching Pad: Economic Community of West African States (ECOWAS)
and Neighboring States
Benin
Burkina Faso
Cameroun
Cape Verde Initial Goal: Establish
Congo Brazzaville presence and brand
Cote d’Ivoire recognition in ECOWAS
Equatorial Guinea and Neighboring
Gabon
Countries
Gambia
Ghana Expansion into all
Guinea countries in Sub‐
Guinea Bissau Ghana
Saharan Africa
Liberia
Mali Nigeria
Mauritania
Niger
Nigeria
Senegal Stage I market
Sierra Leone
Stage II market
Building a quality
brand name
LaGray synonymous
with Excellence
LaGray Chemical Company
Nsawam, Ghana
+233.832.22332
info@[Link]
[Link]
4